• Home
  • Trends
  • Company News
  • Product News
  • Fashion
  • Podcast
  • Events
  • About
  • Contact
  • May 9, 2025

Wearable Tech Insider

The Inside Word on Wearables and Wearable Technology

You are here: Home / Medical / Implantables at WearableTechLA

Implantables at WearableTechLA

July 17, 2014 By Dan Rosenbaum

Sensors that analyze your sweat and implanted devices that promise to help the brain regulate organs were the topic of conversation earlier today at a WearableTechLA panel moderated by Wearable Tech Insider.

Dr. Victor Pikov, a senior scientist at the Huntington Medical Research Institute in Pasadena, CA, said that GSK and DARPA are putting a combined $100 million of dollars into investigating brain mapping and the interaction between the brain and how it regulates your body. (The DARPA project is called the BRAIN Initiative.) Rather than, for instance, stimulating your pancreas to produce more insulin, the idea is to understand what about the communication between your brain and your pancreas is causing it to not produce the insulin in the first place.

This isn’t a product-tomorrow kind of thing; Pikov said it will be three years before research will start to be done, and maybe another three years before medical trials even begin.

Electrozyme, said CEO Joshua Windmiller, is producing sensors on temporary screen-printed tattoos that can analyze sweat for lactate (a sign of anaerobic exercise), hydration and electrolyte, and ammonia (which is excreted when muscle is breaking down). The company got its start doing research for the Navy, in work that we first heard about earlier this year at the Flextech 2014 conference. Note that this work happens non-invasively; it’s chemistry done on the surface of the skin at very small scale and very low power consumption.

Windmiller said that Electrozyme isn’t interested in producing end-user product; it’s more than happy making the advanced sensors that will find their way into commercial products.

[youtube https://youtu.be/Kx_KnL0WcFQ]

 

Last updated by Dan Rosenbaum on August 5, 2014.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email

Related

Filed Under: Medical Tagged With: darpa, electrozyme, gsk, implantables, pikov, windmiller

← Heapsylon Lands $5 Million in Funding; Changes Name to Sensoria Apple iTime Patent Hints at What Might Be Coming →

Recent Posts

New Use Case for Apple Watch: Red Sox Stealing Signs

Fossil Debuts Two Android Wear Smartwatches

Garmin Shows Three New Fitness Bands at IFA

Fitbit Ionic: Minimal Acceptable Product?

Intel (Finally) Ditches Wearables for AR

Don’t Believe Everything You Read: Wearables Are Far From Dead

Eyes F.lashing Before Your Life

Smarty Pants: Nadi X Yoga Leggings

Rings: How Smart Can They Be?

Upskill Closes Series B Financing, But Won’t Say How Much

Stories from Health Tech Insider

  • Remote Monitoring Drives New Personalized Treatment for Chronic Breathing Problems
  • Wearable Technology Listens for Knee Damage [video]
  • New Bandages Promise Faster Healing for Stubborn Wounds
  • CVS Acquires Telehealth Service to Bring Healthcare to the Home
  • Masimo’s New Smartwatch Addresses Privacy Concerns
  • Continuous Real-Time Diagnostics On the Go [video]

Topics

2013 android android wear apple apple watch apx labs basis battery CES ces2016 CES2017 epson finance fitbit fitness fossil fuelband garmin gear glass google healthkit intel iWatch jawbone LG market research microsoft misfit MWC15 nfc nike omate omsignal pebble recon samsung smartwatch sony sports tizen vuzix withings wristware wristwear

Copyright 2016 Center Ring Media | Site by JRMC